scholarly journals Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster Vaccine

2018 ◽  
Vol 219 (2) ◽  
pp. 335-338 ◽  
Author(s):  
Adriana Weinberg ◽  
Zoran Popmihajlov ◽  
Kenneth E Schmader ◽  
Michael J Johnson ◽  
Yupanqui Caldas ◽  
...  
2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Adriana Weinberg ◽  
Myron Levin ◽  
Kenneth Schmader ◽  
Michael Johnson ◽  
Yupanqui Caldas ◽  
...  

2009 ◽  
Vol 200 (7) ◽  
pp. 1068-1077 ◽  
Author(s):  
Adriana Weinberg ◽  
Jane H. Zhang ◽  
Michael N. Oxman ◽  
Gary R. Johnson ◽  
Anthony R. Hayward ◽  
...  

Vaccines ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 572
Author(s):  
Mina Psichogiou ◽  
Michael Samarkos ◽  
Nikolaos Mikos ◽  
Angelos Hatzakis

Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7–20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1–21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ. These cases support the importance of continuing assessment of vaccine safety during the ongoing massive vaccination for the COVID-19 pandemic and encourage reporting and communication of any vaccination-associated adverse event.


2018 ◽  
Vol 217 (7) ◽  
pp. 1055-1059 ◽  
Author(s):  
Myron J Levin ◽  
Guang-Yun Cai ◽  
Katherine S Lee ◽  
Nadine G Rouphael ◽  
Aneesh K Mehta ◽  
...  

2014 ◽  
Vol 58 (8) ◽  
pp. 1125-1128 ◽  
Author(s):  
H. F. Tseng ◽  
D. S. Schmid ◽  
R. Harpaz ◽  
P. LaRussa ◽  
N. J. Jensen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document